16:48 EDT DBV Technologies (DBVT) jumps 80% to $1.26 after Viaskin regulatory update Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on DBVT: DBV Technologies completes patient screening for VITESSE trial Disclaimer & DisclosureReport an Issue
